About Golgi-associated RAB2 interactor protein 1B
Golgi-associated RAB2 interactor protein 1B (GARIN1B) is a protein
from Homo sapiens identified by UniProt accession
Q96KD3, 344 residues long.
MolForge cross-references it against 0 known binders and
93 disease associations.
Target properties
| Protein name | Golgi-associated RAB2 interactor protein 1B |
| UniProt accession | Q96KD3 |
| Gene | GARIN1B |
| Organism | Homo sapiens |
| Length | 344 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (93)
Diseases linked to this target (Open Targets).
- atrial fibrillation · score 0.17
- atrial flutter · score 0.17
- azoospermia · score 0.10
- male infertility with teratozoospermia due to single gene mutation · score 0.09
- partial chromosome Y deletion · score 0.07
- spermatogenic failure 72 · score 0.07
- spermatogenic failure 27 · score 0.07
- spermatogenic failure 46 · score 0.07
- spermatogenic failure 18 · score 0.07
- spermatogenic failure 49 · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96KD3-F1 | alphafold | PREDICTED | 61.93 | — |
Amino-acid sequence (344 residues)
MLSSFPHRKT WRKSKKTVKV TRSYPTFPSL NAWEEFRGLL PVDGEPNPGA GLGVEEGLLC RVVHSPEFNL FLDSVVFESN FIQVKRGRNW RDVYKASNTM ALGVTSSVPC LPLPNILLMA SVKWHQGQNQ TWNRPSIAPN IFLKRILPLR FVELQVCDHY QRILQLRTVT EKIYYLKLHP DHPETVFHFW IRLVQILQKG LSITTKDPRI LVTHCLVPKN CSSPSGDSKL VQKKLQASQP SESLIQLMTK GESEALSQIF ADLHQQNQLS FRSSRKVETN KNSSGKDSSR EDSIPCTCDL RWRASFTYGE WERENPSGLQ PLSLLSTLAA STGPQLAPPI GNSI
Explore Golgi-associated RAB2 interactor protein 1B with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets